Moreover, Mazaki-Tovi et al. determined that maternal GDM and fetal hypertrophy are independently associated with high plasma visfatin levels, indicating its potential usefulness as a diagnostic/prognostic factor for GDM screening [104]. Here, NAMPT is linked to gestational diabetes.